Credit Suisse’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-136
| Closed | -$1K | – | 4310 |
|
|
2022
Q2 | $1K | Buy |
+136
| New | +$1K | ﹤0.01% | 3829 |
|
|
2021
Q1 | – | Sell |
-601
| Closed | -$69K | – | 3573 |
|
|
2020
Q4 | $69K | Buy |
601
+451
| +301% | +$51.8K | ﹤0.01% | 3359 |
|
|
2020
Q3 | $18K | Sell |
150
-50
| -25% | -$6K | ﹤0.01% | 3219 |
|
|
2020
Q2 | $25K | Buy |
+200
| New | +$25K | ﹤0.01% | 3255 |
|